Breaking News

The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art Eosinófilos para acortar la corticoterapia en la exacerbación asmáticaUna estrategia prometedora pendiente de confirmación Cambio a depemokimab cada seis meses en pacientes con asma grave previamente tratados con mepolizumab o benralizumab Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma

riesgo cardiovascular

032

Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma

Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma

14 octubre, 2026 Like 0 Revisiones Asma

Revisor: Javier Díez Sierra. Servicio de Neumología. Hospital Universitario Vi..

Leer más

Categorías